GE Healthcare played to high-field enthusiasts visiting the RSNA exhibit floor Sunday, unveiling three MR scanners – one at 3T and two at 1.5T.
GE Healthcare played to high-field enthusiasts visiting the RSNA exhibit floor Sunday, unveiling three MR scanners - one at 3T and two at 1.5T.
The Signa HDx 3T and Signa HDx 1.5T are built on a 32-channel architecture and support advanced clinical applications, including PROPELLER for motion-resistant brain imaging, VIBRANT-XV breast scanning, LAVA-XV body imaging, and TRICKS-XV time-resolved angiography. The Signa HDe, a value-driven 1.5T scanner, comes in four- and eight-channel configurations, and sports a small footprint for easy installation.
The 3T and premium 1.5T systems feature a new XVRE reconstruction engine; advanced parallel imaging algorithms; new acquisition strategies; and an interlocking, high-density head, neck, and spine coil system.
Signa HDx 3T utilizes high-density coils developed for the company's previously launched HD 3T system, which will remain in the GE line-up. New this year is the Signa HD breast coil, which supports multi-dimensional parallel imaging and biopsy capability, and a high-density hybrid extremity coil.
Signa HDx takes the flagship position in GE's 1.5T portfolio. It utilizes a Signa HD peripheral vascular lower leg array, which provides images of the lower leg and foot vessels.
The value-oriented Signa HDe 1.5T builds on the high definition platform, but offers lower operating costs and requires less overall siting space. With a 30% smaller footprint than a typical 1.5T system, the scanner can be sited where most 1.5T MR systems cannot, according to the company. Installation can be performed in about one week.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.